Analysts Offer Insights on Real Estate Companies: Omega Healthcare (OHI), Jones Lang Lasalle (JLL) and Cushman & Wakefield (CWK)
Companies in the Real Estate sector have received a lot of coverage today as analysts weigh in on Omega Healthcare (OHI), Jones Lang Lasalle (JLL) and Cushman & Wakefield (CWK).
Claim 55% Off TipRanks
- Unlock trusted, data-backed investing tools with TipRanks Premium, from analyst ratings and forecasts to breaking news and portfolio analysis.
- Discover high-conviction stock picks and new investing opportunities with the TipRanks Smart Investor Newsletter
Omega Healthcare (OHI)
In a report released yesterday, Julien Blouin from Goldman Sachs maintained a Buy rating on Omega Healthcare, with a price target of $63.00. The company’s shares closed last Tuesday at $44.81.
According to TipRanks.com, Blouin is a 2-star analyst with an average return of
Omega Healthcare has an analyst consensus of Moderate Buy, with a price target consensus of $51.20, representing a 13.1% upside. In a report issued on May 22, TipRanks – PerPlexity also reiterated a Buy rating on the stock with a $58.00 price target.
See the top stocks recommended by analysts >>
Jones Lang Lasalle (JLL)
William Blair analyst Stephen Sheldon maintained a Buy rating on Jones Lang Lasalle today. The company’s shares closed last Tuesday at $295.99.
According to TipRanks.com, Sheldon is currently ranked with 0 stars on a 0-5 stars ranking scale, with an average return of
Jones Lang Lasalle has an analyst consensus of Strong Buy, with a price target consensus of $402.20, a 42.5% upside from current levels. In a report released yesterday, J.P. Morgan also maintained a Buy rating on the stock with a $403.00 price target.
Cushman & Wakefield (CWK)
In a report released yesterday, Anthony Paolone from J.P. Morgan maintained a Hold rating on Cushman & Wakefield, with a price target of $18.00. The company’s shares closed last Tuesday at $13.12.
According to TipRanks.com, Paolone is a 3-star analyst with an average return of
Currently, the analyst consensus on Cushman & Wakefield is a Moderate Buy with an average price target of $16.67, which is a 34.4% upside from current levels. In a report issued on May 22, Barclays also maintained a Hold rating on the stock with a $15.00 price target.
Read More on OHI:
Disclaimer & DisclosureReport an Issue
- Omega Healthcare price target raised to $49 from $46 at BofA
- Omega Healthcare unveils leadership succession and governance transition
- Omega Healthcare announces retirement of CEO Pickett
- Omega Healthcare price target raised to $50 from $48 at Scotiabank
- Omega Healthcare price target raised to $54 from $52 at UBS
